Elis­a­bet de los Pinos and her team fu­el up for a late-stage quest to de­liv­er a safe eye can­cer drug

Since its found­ing in 2009, Au­ra Bio­sciences has been laser-fo­cused on cre­at­ing a safer al­ter­na­tive to cur­rent­ly avail­able eye can­cer ther­a­pies. And on Mon­day, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.